Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Common Stock
2021-03-12+11,875→ 47,685 total - Award
Stock Option (Right to Buy)
2021-03-12+71,250→ 71,250 totalExercise: $9.99Exp: 2031-03-11→ Common Stock (71,250 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
- [F2]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.